TYK Medicines, Inc (02410.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 3.37

From 52W high−83.31%

Volume1.25M

Market capHKD 1.22B

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

HKD 3.37

From 52W high

−83.31%

Volume

1.25M

Market cap

HKD 1.22B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.5x

P/E (TTM)

—

RSI (14)

32.3

MomentumView details →

1D Return

−1.51%

YTD Return

−75.17%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−3.5x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

−1.0x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

27.90%

ROA (TTM)

−55.17%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

−100.00%

EPS CAGR 3Y

+32.17%

EBITDA YoY

—

MomentumView details →

1D Return

−1.51%

YTD Return

−75.17%

1Y Return

−78.56%

RSI (14)

32.3

vs 50D SMA

−47.45%

vs 200D SMA

−66.04%

Capital & dividendView details →

Debt/Equity

−0.12x

Current Ratio

0.14x

Quick Ratio

0.14x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−HKD 0.08

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−423.91M

Op. CF (TTM)

—

Next earningsApr 1, 2027 →

Latest newsMore news →

Tongyuantang Pharmaceutical (02410) announced that its subscription agreement to issue 63.2227 million H shares to Qilu lapsed on September 20, 2026 after the revised long-stop date passed without the conditions being fulfilled or waived.2h ago

Tongyuankang Medical's chairman Wu Yusheng purchased shares in the open market and plans to increase holdings by up to 2 million yuan.12d ago

Similar companies

Fangzhou Inc.06086.HK Beijing Biostar Pharms Co Ltd02563.HK 天目药业600671.SH Modern Chinese Medicine Group Co., Ltd.01643.HK Organon & Co.OGN Impact Therap-b07630.HK Find similar companies →

Latest newsMore news →

Tongyuantang Pharmaceutical (02410) announced that its subscription agreement to issue 63.2227 million H shares to Qilu lapsed on September 20, 2026 after the revised long-stop date passed without the conditions being fulfilled or waived.2h ago Tongyuankang Medical's chairman Wu Yusheng purchased shares in the open market and plans to increase holdings by up to 2 million yuan.12d ago